CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients.

Gang NingYongqiang LiWenji ChenWenjuan TangDi-Wen ShouQingling LuoHui-Ting Chen Yong Jian Zhou

Published in: Journal of oncology (2021)

The CIMP may modulate the immune response of the tumor microenvironment and influence the prognosis of pancreatic cancer patients, which may help to make an assertion to provide specific and efficient treatment options for patients of different subtypes.

Keyphrases

immune response
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
dna methylation
dendritic cells
prognostic factors
peritoneal dialysis
toll like receptor
gene expression
patient reported outcomes
patient reported
inflammatory response